Worldwide Study Finder

Loading registry information…

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 22:07 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase not reported / not applicableCompletedOBSERVATIONAL

Natural Cycles With Spontaneous Versus Induced Ovulation in FET

ClinicalTrials.gov · NCT03581422 · Registry updated: 2018-07-19

Condition / research focus: Embryo Transfer
Sponsor: Istituto Clinico Humanitas
Countries with listed sites: No country reported
Registry dates and results: Start: 2012-01-01. Completion: 2017-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG administration before embryo transfer (drug) — also listed as: Gonasi HP 5000 UI or Ovitrelle 250mg

Where the study takes place — 0 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Phase 3CompletedINTERVENTIONAL

Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia

ClinicalTrials.gov · NCT00003702 · Registry updated: 2018-05-15

Condition / research focus: Good Prognosis Metastatic Gestational Trophoblastic Tumor; Hydatidiform Mole; Non-Metastatic Gestational Trophoblastic Tumor; Uterine Corpus Choriocarcinoma
Sponsor: Gynecologic Oncology Group
Countries with listed sites: United States
Registry dates and results: Start: 1999-06. Completion: Not reported (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dactinomycin (biological) — also listed as: Actinomycin A IV, Actinomycin C1, ACTINOMYCIN D, Actinomycin I1, Actinomycin IV, Actinomycin X 1, Actinomycin-[thr-val-pro-sar-meval], Cosmegen, DACT, Dactinomycine, Lyovac Cosmegen, Meractinomycin
Methotrexate (drug) — also listed as: Abitrexate, Alpha-Methopterin, Amethopterin, Brimexate, CL 14377, CL-14377, Emtexate, Emthexat, Emthexate, Farmitrexat, Fauldexato, Folex, Folex PFS, Lantarel, Ledertrexate, Lumexon, Maxtrex, Medsatrexate, Metex, Methoblastin, Methotrexate LPF, Methotrexate Methylaminopterin, Methotrexatum, Metotrexato, Metrotex, Mexate, Mexate-AQ, MTX, Novatrex, Rheumatrex, Texate, Tremetex, Trexeron, Trixilem, WR-19039

Where the study takes place — 1 listed sites

Gynecologic Oncology Group
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Worldwide Study Finder

Worldwide Study Finder

Find a study

Registry search results

Natural Cycles With Spontaneous Versus Induced Ovulation in FET

Explore the world’s study registries

Worldwide

Africa

Americas

Feasibility Study of an Automated Point-of-Care Urine Diagnostic Device for Pregnancy

A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation

Measuring hCG Levels in Pregnant Women

Differential Regulation of VEGF, Cadherin, Angiopietin 2 by Trigger Oocyte Maturation With GnRHa vs hCG in Donors

Oral Probiotic Administration to Modulate the Airway Microbiome in Obese Asthmatic Subjects

"Stair Step Study"

Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)

Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome

Endometrial Preparation in Frozen Embryo Transfer Cycles

Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia

Delayed Embryo Transfer in Poor Responders

Role of Heparin in Poor Responders Undergoing In Vitro Fertilisation

STA-9090 in Patients With Advanced Hepatocellular Cancer

The Influence of Timing of Cabergoline Initiation on Prevention of OHSS

Natural Cycle In Vitro Fertilization

Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization

Prediction of Metaphase II Oocytes According to Different Levels of Serum AMH in Poor Responders Using the Antagonist Protocol

Second Step Protocol in Poor Ovarian Responder (POR)

Safety and Efficacy of Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing in Vitro Fertilization (IVF)

Asia

Middle East

Europe

Oceania